Stereotaxis Receives CE Mark Recertification Under EU’s MDR Regulatory Framework
ST. LOUIS, May 24, 2024 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for […]
Lilium Announces Pricing of $114 Million Financing
MUNICH, Germany, May 24, 2024 (GLOBE NEWSWIRE) — Lilium N.V. (NASDAQ: LILM) (“Lilium” or the “Company”), developer of the first […]
Hudbay Completes Upsized Bought Deal Equity Offering
TORONTO, May 24, 2024 (GLOBE NEWSWIRE) — Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) is pleased to […]
Roadzen to Participate in Fireside Chat at the Maxim Group TMT Conference on June 4, 2024
NEW YORK, May 24, 2024 (GLOBE NEWSWIRE) — Roadzen Inc. (Nasdaq: RDZN) (“Roadzen” or the “Company”), a global leader in […]
Safe & Green Holdings Receives Crucial International Code Council (ICC), Recertification for Use of Shipping Containers in Modular Construction
Shipping container used in modular construction MIAMI, FL, May 24, 2024 (GLOBE NEWSWIRE) — Safe & Green Holdings Corp. (NASDAQ: […]
The Children’s Place, Inc. Issues Chairman’s Letter to Shareholders
SECAUCUS, N.J., May 24, 2024 (GLOBE NEWSWIRE) — The Children’s Place, Inc. (Nasdaq: PLCE), an omni-channel children’s specialty portfolio of brands […]
Rail Vision Reflects on Positive Operational Highlights Since the Start of 2024: Scaling Up Commercialization
Announced first-ever commercial installation of its AI-driven systems in a national railways line Achieved regulatory approval and certificate for railway […]
Perspective Therapeutics Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
SEATTLE, May 24, 2024 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company […]
Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants
WESTLAKE VILLAGE, Calif., May 24, 2024 (GLOBE NEWSWIRE) — Genelux Corporation (Genelux) (Nasdaq: GNLX), a late clinical-stage immuno-oncology company, today […]
Monopar Announces CFO Succession
WILMETTE, Ill., May 24, 2024 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharmaceutical company focused on developing […]
